|
|
 |
|
Visual Acuity |  |
|
|
The first 2 years of therapy . . .
Patients receiving Visudyne retained significantly more visual acuity*
Early and successive interventions significantly improved 1- and 2-year outcomes3,4
- At 1 year, patients receiving Visudyne therapy were 72% more likely to achieve vision preservation vs placebo2
- Almost twice as many patients improved visual acuity (13% vs
7%, P<.001)2
- At 2 years, patients receiving Visudyne were 90% more likely to achieve vision preservation4
Significantly reduced the risk of severe vision loss
- Visudyne patients were 72% more likely to maintain visual acuity of 20/160 or better2
|
|
